Tracheobronchitis in ulcerative colitis: a case report of therapeutic response with infliximab and review of the literature

被引:7
作者
Horgan, Lisa [1 ]
Mulrennan, Siobhain [2 ,3 ]
D'Orsogna, Lloyd [3 ,4 ]
McLean-Tooke, Andrew [1 ,5 ]
机构
[1] Sir Charles Gairdner Hosp, Dept Immunol, Perth, WA 6009, Australia
[2] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA 6009, Australia
[3] Univ Western Australia, Fac Hlth & Med Sci, Perth, WA 6009, Australia
[4] Fiona Stanley Hosp, Dept Immunol, Perth, Australia
[5] QEII, Pathwest, Nedlands, WA, Australia
关键词
Ulcerative colitis; Inflammatory bowel disease; Tracheobronchitis; NECROSIS-FACTOR-ALPHA; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; PULMONARY-FUNCTION; LUNG; PATIENT; INVOLVEMENT; STRIDOR;
D O I
10.1186/s12876-019-1091-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The extra-intestinal manifestation of tracheobronchitis is a rare complication of ulcerative colitis (UC). Here, we present a case of UC-related tracheobronchitis wherein the positive clinical effects of infliximab are demonstrated. Case presentation: We report the case of a 39-year old woman who presented with a chronic productive cough on a distant background of surgically managed ulcerative colitis (UC). Our patient failed to achieve a satisfactory clinical improvement despite treatment with high dose inhaled corticosteroids, oral corticosteroids and azathioprine. Infliximab therapy was commenced and was demonstrated to achieve macroscopic and symptomatic remission of disease. Conclusions: We present the first case report documenting the benefits of infliximab in UC-related tracheobronchitis.
引用
收藏
页数:7
相关论文
共 40 条
[1]  
Alrashid AI, 2001, DIGEST DIS SCI, V46, P1736, DOI 10.1023/A:1010665807294
[2]   A rare extraintestinal manifestation of ulcerative colitis: Tracheobronchitis associated with ulcerative colitis [J].
Bayraktaroglu, Selen ;
Basoglu, Ozen ;
Ceylan, Naim ;
Aydin, Ahmet ;
Tuncel, Senay ;
Savas, Recep .
JOURNAL OF CROHNS & COLITIS, 2010, 4 (06) :679-682
[3]   Thoracic manifestations of inflammatory bowel disease [J].
Black, Hugh ;
Mendoza, Mark ;
Murin, Susan .
CHEST, 2007, 131 (02) :524-532
[4]   Review article: acute severe ulcerative colitis - evidence-based consensus statements [J].
Chen, J-H. ;
Andrews, J. M. ;
Kariyawasam, V. ;
Moran, N. ;
Gounder, P. ;
Collins, G. ;
Walsh, A. J. ;
Connor, S. ;
Lee, T. W. T. ;
Koh, C. E. ;
Chang, J. ;
Paramsothy, S. ;
Tattersall, S. ;
Lemberg, D. A. ;
Radford-Smith, G. ;
Lawrance, I. C. ;
McLachlan, A. ;
Moore, G. T. ;
Corte, C. ;
Katelaris, P. ;
Leong, R. W. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (02) :127-144
[5]   Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID) - A clinicopathologic study and review [J].
Daniels, Jason A. ;
Lederman, Howard M. ;
Maitra, Anirban ;
Montgomery, Elizabeth A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (12) :1800-1812
[6]   Molecular Embryology of the Foregut [J].
Faure, Sandrine ;
Barbara, Pascal de Santa .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 52 :S2-S3
[7]  
Garg K, 1993, J Thorac Imaging, V8, P159, DOI 10.1097/00005382-199321000-00010
[8]   Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease [J].
Gill, KRS ;
Mahadevan, U .
INFLAMMATORY BOWEL DISEASES, 2005, 11 (02) :210-212
[9]  
Godet PG, 1997, AM J GASTROENTEROL, V92, P1154
[10]   Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549